Organon (OGN) shares rose more than 7% in Friday's premarket activity amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.
Organon would merge with Sun Pharmaceutical if an agreement is reached, according to a report from the Economic Times. Sun Pharma is competing with other major players, the report added.
Organon and Sun Pharmaceutical did not immediately respond to MT Newswires' requests for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 9.28, Change: +0.68, Percent Change: +7.89
Comments